Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol
- PMID: 2411566
- DOI: 10.1007/BF00544356
Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol
Abstract
The effects on intraocular pressure (IOP) and haemodynamics of two beta-blockers, arotinolol and timolol, administered topically to the eye, were studied in 6 healthy volunteers in a cross-over trial. 0.5% timolol or 0.5% arotinolol ophthalmic solutions drop was instilled in both eyes of the volunteers at an interval of 48 hours. Timolol lowered IOP by about 31.9% 1 hour after administration and the effect continued until 3 h, whilst arotinolol lowered it significantly 2 h after instillation and the same maximum effect as that of timolol was obtained after 3 h. Arotinolol was detected in blood in all subject and timolol in blood in one subject, although it was found in all subjects in urine. Both drugs lowered heart rate at rest and attenuated the increase in the double product (products of blood pressure and heart rate) at exercise. The effect of timolol on the double products was larger. Thus, arotinolol and timolol decreased IOP to similar extent, although the maximal effect of arotinolol was delayed. Arotinolol as well as timolol affected haemodynamics through absorption into circulation, but the former had less effect on haemodynamics during exercise.
Similar articles
-
Dynamics and kinetics of ophthalmic timolol.Clin Pharmacol Ther. 1980 Apr;27(4):471-7. doi: 10.1038/clpt.1980.66. Clin Pharmacol Ther. 1980. PMID: 7357805 Clinical Trial.
-
Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.Br J Ophthalmol. 1988 Feb;72(2):101-3. doi: 10.1136/bjo.72.2.101. Br J Ophthalmol. 1988. PMID: 3349009 Free PMC article. Clinical Trial.
-
Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers.Ophthalmic Res. 1997;29(3):139-44. doi: 10.1159/000268008. Ophthalmic Res. 1997. PMID: 9211466 Clinical Trial.
-
Systemic side effects associated with the ophthalmic administration of timolol.Drug Intell Clin Pharm. 1985 Feb;19(2):85-9. doi: 10.1177/106002808501900201. Drug Intell Clin Pharm. 1985. PMID: 3882377 Review.
-
Pharmaceutical agents and the prevention or reduction of progressive myopia.Acta Ophthalmol Suppl (1985). 1988;185:134-8. doi: 10.1111/j.1755-3768.1988.tb02689.x. Acta Ophthalmol Suppl (1985). 1988. PMID: 2853520 Review. No abstract available.
Cited by
-
Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.Trans Am Ophthalmol Soc. 1990;88:149-59; discussion 159-62. Trans Am Ophthalmol Soc. 1990. PMID: 1982747 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources